Ligand · YSL
YSL · (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)nonan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-methylidene-cyclohexane-1,3-diol
YSL, (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)nonan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-methylidene-cyclohexane-1,3-diol (C30 H50 O3, 458.7 g/mol), in the MolNFT structures on…
- Component
- YSL
- Formula
- C30 H50 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
YSL in 2 structures; the first of them:
- 5AWJ · Crystal structure of VDR-LBD/partial agonist complex: 22S-hexyl analogue · YSL A501 · binds TYR143, TYR147, PHE150, LEU226, LEU229, VAL230, SER233, ILE264 and 15 more
- 5AWJ · Crystal structure of vdr-LBD/PARTIAL agonist complex: 22S-hexyl analogue · YSL A501 · binds TYR143, TYR147, PHE150, LEU226, LEU229, VAL230, SER233, ILE264 and 15 more
Residues it binds most
LEU 2, SER 2, TYR 2, HIS 2, ILE 2, PHE 2, VAL 2, ARG 2, CYS 2, MET 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.